🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to describe the safety and IOP-lowering effic...
Status
Completed
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00670033
The purpose of the study is to evaluate the safety and effectiveness of an ...
Status
Completed
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT00293800
The purpose of this study is to compare the incremental dosing of travopros...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01298687
The purpose of this study is to compare the safety and IOP-lowering efficac...
Status
Completed
Location
Contact Alcon Call Center at 1-888-451-3937
Start Date
2007-10
Trial ID
NCT00637130
The purpose of this study is to evaluate the intraocular pressure (IOP)-low...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01652664
The purpose of this study is to evaluate the additive intraocular pressure ...
Status
Terminated
Location
Contact Alcon for Locations (Europe, Asia, and Latin America)
Start Date
2016-06-24
Trial ID
NCT02730871
To evaluate the safety and IOP lowering efficacy of OTX-TP, a sustained rel...
Status
Completed
Location
Vold Vision
Start Date
2014-11
Trial ID
NCT02312544
The purpose of this study is to compare the intraocular pressure (IOP)-lowe...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00333125
The purpose of the study is to evaluate the safety and effectiveness of an ...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT00293787
The purpose of this study is to demonstrate the additive effect of brinzola...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01937299